S&P 500   3,243.63 (-1.57%)
DOW   28,535.80 (-1.57%)
QQQ   218.10 (-2.07%)
AAPL   308.95 (-2.94%)
FB   214.87 (-1.41%)
MSFT   162.28 (-1.67%)
GOOGL   1,431.73 (-2.35%)
AMZN   1,828.34 (-1.79%)
CGC   21.56 (-4.81%)
NVDA   240.20 (-4.10%)
BABA   205.47 (-3.87%)
MU   55.41 (-4.07%)
GE   11.44 (-2.31%)
TSLA   558.02 (-1.20%)
AMD   49.26 (-2.16%)
T   38.25 (-0.65%)
ACB   1.89 (-5.03%)
F   8.89 (-1.22%)
NFLX   342.88 (-2.91%)
PRI   119.08 (-2.82%)
BAC   32.85 (-2.06%)
DIS   135.90 (-2.98%)
GILD   63.83 (+1.08%)
S&P 500   3,243.63 (-1.57%)
DOW   28,535.80 (-1.57%)
QQQ   218.10 (-2.07%)
AAPL   308.95 (-2.94%)
FB   214.87 (-1.41%)
MSFT   162.28 (-1.67%)
GOOGL   1,431.73 (-2.35%)
AMZN   1,828.34 (-1.79%)
CGC   21.56 (-4.81%)
NVDA   240.20 (-4.10%)
BABA   205.47 (-3.87%)
MU   55.41 (-4.07%)
GE   11.44 (-2.31%)
TSLA   558.02 (-1.20%)
AMD   49.26 (-2.16%)
T   38.25 (-0.65%)
ACB   1.89 (-5.03%)
F   8.89 (-1.22%)
NFLX   342.88 (-2.91%)
PRI   119.08 (-2.82%)
BAC   32.85 (-2.06%)
DIS   135.90 (-2.98%)
GILD   63.83 (+1.08%)
S&P 500   3,243.63 (-1.57%)
DOW   28,535.80 (-1.57%)
QQQ   218.10 (-2.07%)
AAPL   308.95 (-2.94%)
FB   214.87 (-1.41%)
MSFT   162.28 (-1.67%)
GOOGL   1,431.73 (-2.35%)
AMZN   1,828.34 (-1.79%)
CGC   21.56 (-4.81%)
NVDA   240.20 (-4.10%)
BABA   205.47 (-3.87%)
MU   55.41 (-4.07%)
GE   11.44 (-2.31%)
TSLA   558.02 (-1.20%)
AMD   49.26 (-2.16%)
T   38.25 (-0.65%)
ACB   1.89 (-5.03%)
F   8.89 (-1.22%)
NFLX   342.88 (-2.91%)
PRI   119.08 (-2.82%)
BAC   32.85 (-2.06%)
DIS   135.90 (-2.98%)
GILD   63.83 (+1.08%)
S&P 500   3,243.63 (-1.57%)
DOW   28,535.80 (-1.57%)
QQQ   218.10 (-2.07%)
AAPL   308.95 (-2.94%)
FB   214.87 (-1.41%)
MSFT   162.28 (-1.67%)
GOOGL   1,431.73 (-2.35%)
AMZN   1,828.34 (-1.79%)
CGC   21.56 (-4.81%)
NVDA   240.20 (-4.10%)
BABA   205.47 (-3.87%)
MU   55.41 (-4.07%)
GE   11.44 (-2.31%)
TSLA   558.02 (-1.20%)
AMD   49.26 (-2.16%)
T   38.25 (-0.65%)
ACB   1.89 (-5.03%)
F   8.89 (-1.22%)
NFLX   342.88 (-2.91%)
PRI   119.08 (-2.82%)
BAC   32.85 (-2.06%)
DIS   135.90 (-2.98%)
GILD   63.83 (+1.08%)
Log in

NASDAQ:APDN - Applied DNA Sciences Stock Price, Forecast & News

$3.86
-0.09 (-2.28 %)
(As of 01/27/2020 04:00 PM ET)
Today's Range
$3.86
Now: $3.86
$4.04
50-Day Range
$3.83
MA: $4.13
$4.46
52-Week Range
$3.52
Now: $3.86
$36.80
Volume75,033 shs
Average Volume153,949 shs
Market Capitalization$13.45 million
P/E RatioN/A
Dividend YieldN/A
Beta0.22
Applied DNA Sciences, Inc develops and markets plat based or other DNA technology solution in the United States, Europe, and Asia. The company's supply chain security and product authentication solutions include SigNature molecular tags that are ingredients used to fortify brand protection efforts and strengthen supply chain security, as well as mark, track, and convict criminals; SigNature T molecular tags, which are tagging and authentication systems for use in brand protection efforts and raw material source compliance programs; and fiberTyping, a test of native cotton fiber DNA. Read More…

Industry, Sector and Symbol

Industry Miscellaneous business services
Sub-IndustryN/A
SectorIndustrial Products
Current SymbolNASDAQ:APDN
CUSIPN/A
Phone631-840-8800

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$5.39 million
Book Value($0.71) per share

Profitability

Net Income$-8,620,000.00
Net Margins-158.74%

Miscellaneous

Employees59
Market Cap$13.45 million
Next Earnings Date2/6/2020 (Estimated)
OptionableOptionable

Receive APDN News and Ratings via Email

Sign-up to receive the latest news and ratings for APDN and its competitors with MarketBeat's FREE daily newsletter.


Applied DNA Sciences (NASDAQ:APDN) Frequently Asked Questions

What is Applied DNA Sciences' stock symbol?

Applied DNA Sciences trades on the NASDAQ under the ticker symbol "APDN."

How were Applied DNA Sciences' earnings last quarter?

Applied DNA Sciences Inc (NASDAQ:APDN) released its quarterly earnings results on Thursday, December, 12th. The technology company reported ($2.63) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($1.26) by $1.37. The technology company had revenue of $1.70 million for the quarter. View Applied DNA Sciences' Earnings History.

When is Applied DNA Sciences' next earnings date?

Applied DNA Sciences is scheduled to release their next quarterly earnings announcement on Thursday, February 6th 2020. View Earnings Estimates for Applied DNA Sciences.

What price target have analysts set for APDN?

1 Wall Street analysts have issued 12 month price targets for Applied DNA Sciences' stock. Their forecasts range from $8.00 to $8.00. On average, they anticipate Applied DNA Sciences' stock price to reach $8.00 in the next twelve months. This suggests a possible upside of 107.3% from the stock's current price. View Analyst Price Targets for Applied DNA Sciences.

What is the consensus analysts' recommendation for Applied DNA Sciences?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Applied DNA Sciences in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Applied DNA Sciences.

Has Applied DNA Sciences been receiving favorable news coverage?

Media stories about APDN stock have trended somewhat negative recently, according to InfoTrie Sentiment Analysis. InfoTrie rates the sentiment of press coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Applied DNA Sciences earned a news sentiment score of -1.4 on InfoTrie's scale. They also assigned news articles about the technology company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the near future. View News Stories for Applied DNA Sciences.

Are investors shorting Applied DNA Sciences?

Applied DNA Sciences saw a decrease in short interest in January. As of January 15th, there was short interest totalling 100,800 shares, a decrease of 53.2% from the December 31st total of 215,400 shares. Based on an average daily volume of 524,100 shares, the days-to-cover ratio is currently 0.2 days. Currently, 2.9% of the company's shares are sold short. View Applied DNA Sciences' Current Options Chain.

Who are some of Applied DNA Sciences' key competitors?

What other stocks do shareholders of Applied DNA Sciences own?

Who are Applied DNA Sciences' key executives?

Applied DNA Sciences' management team includes the folowing people:
  • Dr. James A. Hayward Ph.D., Sc.D., Pres, CEO & Chairman (Age 65)
  • Ms. Beth M. Jantzen CPA, CPA, Chief Financial Officer (Age 43)
  • Ms. Judith Murrah, Chief Information Officer & Sec. (Age 61)
  • Mr. Clay Shorrock Esq., Gen. Counsel
  • Mr. Tony Benson, Managing Director of EMEA

How do I buy shares of Applied DNA Sciences?

Shares of APDN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Applied DNA Sciences' stock price today?

One share of APDN stock can currently be purchased for approximately $3.86.

How big of a company is Applied DNA Sciences?

Applied DNA Sciences has a market capitalization of $13.45 million and generates $5.39 million in revenue each year. Applied DNA Sciences employs 59 workers across the globe.View Additional Information About Applied DNA Sciences.

What is Applied DNA Sciences' official website?

The official website for Applied DNA Sciences is http://www.adnas.com/.

How can I contact Applied DNA Sciences?

Applied DNA Sciences' mailing address is 50 HEALTH SCIENCES DRIVE, STONY BROOK NY, 11790. The technology company can be reached via phone at 631-840-8800 or via email at [email protected]


MarketBeat Community Rating for Applied DNA Sciences (NASDAQ APDN)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  237 (Vote Outperform)
Underperform Votes:  222 (Vote Underperform)
Total Votes:  459
MarketBeat's community ratings are surveys of what our community members think about Applied DNA Sciences and other stocks. Vote "Outperform" if you believe APDN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe APDN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/27/2020 by MarketBeat.com Staff

Featured Article: Economic Reports

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel